Differentiation of Urothelial Carcinoma and Normal Bladder Tissues by Means of Fiber-Based ATR IR Spectroscopy

Simple Summary Non-muscle-invasive bladder cancer (NMIBC) is a complicated locally treated disease with high recurrence rates and high risk of progression to muscle invasive disease. Current standard diagnostic approach based on white light cystoscopy (WLC) is characterized by high false negative rate, excessive invasion of the bladder and high economic burden. Hereby we present the fiber-based attenuated total reflection infrared (ATR IR) spectroscopy study of healthy and cancerous tissue samples taken from 54 patients to delineate normal and tumorous human bladder tissues under ex vivo conditions. Investigation of the tissue samples immediately after surgical operation allows to examine samples in their native conditions and establish their initial structure and chemical composition avoiding sample degradation. Our study reveals that fiber-based ATR IR spectroscopy could be an addition to current endoscopic approach with increased diagnostic accuracy and with some potential to be applied in vivo. Abstract Surgical treatment is widely applied curative approach for bladder cancer. White light cystoscopy (WLC) is currently used for intraoperative diagnostics of malignant lesions but has relatively high false-negative rate. Here we represent an application of label free fiber-based attenuated total reflection infrared spectroscopy (ATR IR) for freshly resected human bladder tissue examination for 54 patients. Defined molecular spectral markers allow to identify normal and urothelial carcinoma tissues. While methods of statistical analysis (Hierarchical cluster analysis (HCA) and Principal component analysis (PCA)) used for spectral data treatment allow to discriminate tissue types with 91% sensitivity and 96–98% specificity. In the present study the described method was applied for tissue examination under ex vivo conditions. However, after method validation the equipment could be translated from laboratory studies to in situ or even in vivo studies in operating room.

[1]  G. Niaura,et al.  Toward a SERS Diagnostic Tool for Discrimination between Cancerous and Normal Bladder Tissues via Analysis of the Extracellular Fluid , 2022, ACS omega.

[2]  Y. Lotan,et al.  Performance of Narrow Band Imaging (NBI) and Photodynamic Diagnosis (PDD) Fluorescence Imaging Compared to White Light Cystoscopy (WLC) in Detecting Non-Muscle Invasive Bladder Cancer: A Systematic Review and Lesion-Level Diagnostic Meta-Analysis , 2021, Cancers.

[3]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[4]  K. Okoń,et al.  In Vitro Spectroscopy-Based Profiling of Urothelial Carcinoma: A Fourier Transform Infrared and Raman Imaging Study , 2021, Cancers.

[5]  G. Steiner,et al.  Fiber based infrared spectroscopy of cancer tissues , 2020 .

[6]  A. Forsythe,et al.  Humanistic and Economic Burden of Non-Muscle Invasive Bladder Cancer: Results of Two Systematic Literature Reviews , 2020, ClinicoEconomics and outcomes research : CEOR.

[7]  G. Steiner,et al.  Fiber attenuated total reflection infrared spectroscopy of kidney tissue during live surgery , 2020, Journal of biophotonics.

[8]  Manish I. Patel,et al.  Transurethral resection of bladder tumour (TURBT) , 2019, Translational andrology and urology.

[9]  C. Conti,et al.  Investigation of human pancreatic cancer tissues by Fourier Transform Infrared Hyperspectral Imaging , 2019, Journal of biophotonics.

[10]  Shahrokh F. Shariat,et al.  European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update. , 2019, European urology.

[11]  S. Daneshmand,et al.  Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registry. , 2018, Urologic oncology.

[12]  Shuhua Yue,et al.  Raman Spectroscopy and Imaging for Cancer Diagnosis , 2018, Journal of healthcare engineering.

[13]  P. Choyke,et al.  Fluorescence-Guided Surgery , 2017, Front. Oncol..

[14]  G. Steiner,et al.  Optical Analysis of Glioma: Fourier-Transform Infrared Spectroscopy Reveals the IDH1 Mutation Status , 2017, Clinical Cancer Research.

[15]  Ihtesham ur Rehman,et al.  Advances in Fourier transform infrared (FTIR) spectroscopy of biological tissues , 2017 .

[16]  E. Goormaghtigh Infrared imaging in histopathology: Is a unified approach possible? , 2017 .

[17]  Anant Madabhushi,et al.  Emerging Themes in Image Informatics and Molecular Analysis for Digital Pathology. , 2016, Annual review of biomedical engineering.

[18]  Y. Ko,et al.  Decision Based on Narrow Band Imaging Cystoscopy without a Referential Normal Standard Rather Increases Unnecessary Biopsy in Detection of Recurrent Bladder Urothelial Carcinoma Early after Intravesical Instillation , 2015, Cancer research and treatment : official journal of Korean Cancer Association.

[19]  J. Desroches,et al.  Characterization of a Raman spectroscopy probe system for intraoperative brain tissue classification. , 2015, Biomedical optics express.

[20]  K. Shimada,et al.  Exploration of risk factors predicting outcomes for primary T1 high‐grade bladder cancer and validation of the Spanish Urological Club for Oncological Treatment scoring model: Long‐term follow‐up experience at a single institute , 2015, International journal of urology : official journal of the Japanese Urological Association.

[21]  A. Harris,et al.  Glycogen metabolism in cancer. , 2014, Biochemical pharmacology.

[22]  Leanne M. Fullwood,et al.  Vibrational spectroscopy for cancer diagnostics , 2014 .

[23]  Christine Desmedt,et al.  Infrared imaging in breast cancer: automated tissue component recognition and spectral characterization of breast cancer cells as well as the tumor microenvironment. , 2014, The Analyst.

[24]  C. Huck,et al.  Fourier transform infrared imaging analysis in discrimination studies of bladder cancer. , 2013, The Analyst.

[25]  Noel W Clarke,et al.  FTIR microspectroscopy of selected rare diverse sub‐variants of carcinoma of the urinary bladder , 2013, Journal of biophotonics.

[26]  G. Mowatt,et al.  Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: Systematic review and meta-analysis , 2011, International Journal of Technology Assessment in Health Care.

[27]  G. Gouspillou,et al.  Collagen types analysis and differentiation by FTIR spectroscopy , 2009, Analytical and bioanalytical chemistry.

[28]  J Alfred Witjes,et al.  Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. , 2006, European urology.

[29]  P. Howard,et al.  Functional changes in bladder tissue from type III collagen-deficient mice , 2006, Molecular and Cellular Biochemistry.

[30]  Edward Messing,et al.  Surveillance for recurrent bladder cancer using a point-of-care proteomic assay. , 2006, JAMA.

[31]  S. Hewitt,et al.  Infrared spectroscopic imaging for histopathologic recognition , 2005, Nature Biotechnology.

[32]  P. Bannasch Sequential cellular changes during chemical carcinogenesis , 1983, Journal of Cancer Research and Clinical Oncology.